These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38019911)

  • 21. Fluorescent conjugated polymer nanovector for in vivo tracking and regulating the fate of stem cells for restoring infarcted myocardium.
    Jin G; Li W; Song F; Zhao J; Wang M; Liu Q; Li A; Huang G; Xu F
    Acta Biomater; 2020 Jun; 109():195-207. PubMed ID: 32294553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction.
    Li H; Hu D; Chen G; Zheng D; Li S; Lin Y; Hong H; Luo Y; Ke Y; Huang Y; Wu L; Lan T; Wang W; Fang J
    Cell Death Dis; 2021 May; 12(6):505. PubMed ID: 34006853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
    Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
    Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
    Huang P; Wang L; Li Q; Tian X; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Cheng K; Qian L; Yang Y
    Cardiovasc Res; 2020 Feb; 116(2):353-367. PubMed ID: 31119268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model.
    Liu X; Chen H; Zhu W; Chen H; Hu X; Jiang Z; Xu Y; Zhou Y; Wang K; Wang L; Chen P; Hu H; Wang C; Zhang N; Ma Q; Huang M; Hu D; Zhang L; Wu R; Wang Y; Xu Q; Yu H; Wang J
    J Heart Lung Transplant; 2014 Oct; 33(10):1083-92. PubMed ID: 25034794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels: Mesenchymal stem cell encapsulation and regeneration of infarcted hearts.
    Choe G; Kim SW; Park J; Park J; Kim S; Kim YS; Ahn Y; Jung DW; Williams DR; Lee JY
    Biomaterials; 2019 Dec; 225():119513. PubMed ID: 31569016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
    Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
    Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage migration inhibitory factor rejuvenates aged human mesenchymal stem cells and improves myocardial repair.
    Zhang Y; Zhu W; He H; Fan B; Deng R; Hong Y; Liang X; Zhao H; Li X; Zhang F
    Aging (Albany NY); 2019 Dec; 11(24):12641-12660. PubMed ID: 31881006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
    Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
    Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
    [No Abstract]   [Full Text] [Related]  

  • 31. Co-expression of Akt1 and Wnt11 promotes the proliferation and cardiac differentiation of mesenchymal stem cells and attenuates hypoxia/reoxygenation-induced cardiomyocyte apoptosis.
    Chen B; Chen X; Liu C; Li J; Liu F; Huang Y
    Biomed Pharmacother; 2018 Dec; 108():508-514. PubMed ID: 30243083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction.
    Yao J; Jiang SL; Liu W; Liu C; Chen W; Sun L; Liu KY; Jia ZB; Li RK; Tian H
    Rejuvenation Res; 2012 Oct; 15(5):495-506. PubMed ID: 22950427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats.
    Zhang J; Lu Y; Mao Y; Yu Y; Wu T; Zhao W; Zhu Y; Zhao P; Zhang F
    Stem Cell Res Ther; 2022 Jul; 13(1):333. PubMed ID: 35870960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction.
    Chen Y; Zuo J; Chen W; Yang Z; Zhang Y; Hua F; Shao L; Li J; Chen Y; Yu Y; Shen Z
    Stem Cell Res Ther; 2019 Sep; 10(1):295. PubMed ID: 31547872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.
    Hou J; Wang L; Hou J; Guo T; Xing Y; Zheng S; Zhou C; Huang H; Long H; Zhong T; Wu Q; Wang J; Wang T
    Stem Cell Rev Rep; 2015 Dec; 11(6):885-99. PubMed ID: 26275398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth arrest-specific gene 6 transfer promotes mesenchymal stem cell survival and cardiac repair under hypoxia and ischemia via enhanced autocrine signaling and paracrine action.
    Shan S; Liu Z; Guo T; Wang M; Tian S; Zhang Y; Wang K; Zheng H; Zhao X; Zuo P; Wang Y; Li D; Liu C
    Arch Biochem Biophys; 2018 Dec; 660():108-120. PubMed ID: 30365934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
    Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.
    Wisel S; Khan M; Kuppusamy ML; Mohan IK; Chacko SM; Rivera BK; Sun BC; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2009 May; 329(2):543-50. PubMed ID: 19218529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.
    Oskouei BN; Lamirault G; Joseph C; Treuer AV; Landa S; Da Silva J; Hatzistergos K; Dauer M; Balkan W; McNiece I; Hare JM
    Stem Cells Transl Med; 2012 Feb; 1(2):116-24. PubMed ID: 23197758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction.
    Gao L; Bledsoe G; Yin H; Shen B; Chao L; Chao J
    Circ J; 2013; 77(8):2134-44. PubMed ID: 23697984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.